{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-002405","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.048474+00:00","generated_at":"2026-06-28T17:09:30.114000+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mednax reports Q3 GAAP EPS $0.37 from continuing ops, revenue $493M, adjusted EPS $0.46","bullets":["Net revenue $492.9M, up 7% YoY; same-unit revenue +5.9%, driven by 6.5% volume increase.","GAAP EPS $0.37 vs loss $0.03 prior year; Adjusted EPS $0.46 vs $0.37.","Adjusted EBITDA $73.4M vs $72.8M; no CARES Act funds in Q3 2021 vs $14.2M in Q3 2020.","Used $20M to invest in Brave Care; redeemed $750M 5.25% notes in Jan; cut revolver to $600M from $1.2B.","Cash at Sep 30: $358M; net debt $642M; no debt on revolver."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-002405","json":"https://secwatch.observer/filing/0000950170-21-002405.json","markdown":"https://secwatch.observer/filing/0000950170-21-002405.md","text":"https://secwatch.observer/filing/0000950170-21-002405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/0000950170-21-002405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/md-20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:09:30.114000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}